Australia markets open in 2 hours 27 minutes

scPharmaceuticals Inc. (SCPH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.66000.0000 (0.00%)
At close: 04:00PM EDT
4.6600 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 168.01M
Enterprise value 132.27M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.20
Price/book (mrq)4.51
Enterprise value/revenue 9.73
Enterprise value/EBITDA -2.87

Trading information

Stock price history

Beta (5Y monthly) 0.05
52-week change 3-58.50%
S&P500 52-week change 322.38%
52-week high 312.7500
52-week low 34.2500
50-day moving average 35.1612
200-day moving average 36.0749

Share statistics

Avg vol (3-month) 3211.97k
Avg vol (10-day) 3135.14k
Shares outstanding 536.05M
Implied shares outstanding 636.05M
Float 816.5M
% held by insiders 111.65%
% held by institutions 176.45%
Shares short (15 Apr 2024) 44.78M
Short ratio (15 Apr 2024) 420.67
Short % of float (15 Apr 2024) 415.79%
Short % of shares outstanding (15 Apr 2024) 413.26%
Shares short (prior month 15 Mar 2024) 44.65M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-250.28%

Management effectiveness

Return on assets (ttm)-31.67%
Return on equity (ttm)-99.97%

Income statement

Revenue (ttm)13.59M
Revenue per share (ttm)0.35
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -55.37M
Net income avi to common (ttm)-54.81M
Diluted EPS (ttm)-1.4200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)76.99M
Total cash per share (mrq)2.13
Total debt (mrq)40.27M
Total debt/equity (mrq)108.20%
Current ratio (mrq)7.08
Book value per share (mrq)1.03

Cash flow statement

Operating cash flow (ttm)-59.24M
Levered free cash flow (ttm)-40.4M